Core Scientific reported second quarter revenue of $164.2 million, a 42.5% increase from the prior quarter, driven by strong growth in its colocation services. The company posted a significant GAAP net loss of $1.16 billion, or ($3.32) per share, which was primarily driven by a non-cash charge related to the change in fair value of warrants.

Key Highlights

  • The company announced a 15-year partnership with AMD for approximately 530 MW of high-density colocation capacity, representing over $14 billion in potential contracted revenue.
  • Colocation revenue increased 76% sequentially to $136.7 million as Billing Megawatts (MW) grew to 395 MW from 225 MW in the prior quarter.
  • Total leased customer power capacity increased to approximately 1.1 GW, representing over $24 billion in potential total contracted revenue across all customers.
  • Adjusted EBITDA was $41.1 million, a significant increase from $8.9 million in the first quarter of 2026.